
GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma.

GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma.

Today, University of Maryland (UM) Ventures announced the appointment of Darryl L. Carter, MD, co-founder and former vice president of Nora Therapeutics, Inc., as Venture Advisor at the University of Maryland Baltimore’s (UMB) Office of Technology Transfer (OTT). In this role, Dr. Carter, who previously supported UMB’s OTT and entrepreneurially focused inventors as an entrepreneur-in-residence, will assist faculty in turning their technology inventions into commercial opportunities. Dr. Carter will also help support the formation of new UMB technology-based start-up companies.

Zika has been in the spotlight lately with summer in full swing and the Olympics in Rio just around the corner. A company in Montgomery County is working on a vaccine that could save lives.
Emergent Biosolutions was awarded a contract by the U.S. government worth nearly $22 million. Scientists will begin working on the vaccine within just a few days.

Reltio, the enterprise data-driven applications and modern data management Platform as a Service (PaaS) company, announced today that it has raised $22M in Series B funding. Leading the oversubscribed round is one of the world’s largest and most successful VC firms, New Enterprise Associates (NEA). Existing investors, Crosslink Capital and .406 Ventures added to their $10M Series A investment, bringing Reltio’s total venture funding to $32M to date. The new financing will be used to extend Reltio’s leadership position in modern data management through accelerated hiring of talented individuals across all groups, and continued expansion into global markets.
Forbes has published a new feature on the “Best Performing Company in Each State.”
The magazine “tracked the total return of every public company between June 8, 2015, and June 8, 2016, excluding companies that have been trading for less time.” The analysis was based on data from FactSet.

The Maryland Department of Commerce is seeking qualified candidates for the position of Senior Business Development Representative within its Division of Business & Industry Sector Development’s Regional Growth, Business Retention, Expansion and Strategic Rural Development Unit. This position is primarily responsible for attracting businesses, assisting with retention, relocation, and expansion needs and opportunities within the State of Maryland focusing on Montgomery County in the Capital Region. The incumbent will actively market and promote the region’s unique assets providing economic development assistance to businesses, Counties, or economic development organizations in Montgomery County.
![]()
BioAdvance, the operator of a $50 million early stage life sciences fund that work with health-care entrepreneurs in the mid-Atlantic region, invested $2.9 million in companies and technologies targeting human health during fiscal 2016

Subscription boxes are a growing business trend. About a year and a half ago, Fatima Dicko founded mybestbox, a subscription-based business which delivers boxes filled with $75-$100 worth of healthy living materials to subscribers nationwide for $25 each month.

On June 27, 2016, the SEC proposed amendments that, if adopted, would allow more companies to qualify for “smaller reporting company” (SRC) status. The proposed amendments are intended to promote capital formation and reduce disclosure compliance costs for smaller companies while maintaining investor protections.

New York City-based Transfix, an on-demand trucking provider, has raised $22 million in Series B funding. New Enterprise Associates led the round with participation from other investors that included Canvas Ventures, Lerer Hippeau Ventures and Corigin Ventures. In conjunction with the funding, Scott Sandell of NEA has been added to Transfix’s board of directors.